Video

High Cost Drug Launches in Specialty Pharmacy

Author(s):

Lauren Santye, Assistant Editor

Sheila Arquette, RPh, director of pharmacy services at Independent Health, discusses the lessons of high cost drugs such as PCSK9 inhibitors on specialty pharmacy.

Sheila Arquette, RPh, director of pharmacy services at Independent Health, discusses the lessons of high cost drugs such as PCSK9 inhibitors on specialty pharmacy.

Related Videos
Small cell lung cancer -- Image credit: LASZLO | stock.adobe.com
Image credit: TensorSpark | stock.adobe.com
Related Content
CDC office in Atlanta, Georgia | Image Credit: © Tada Images - stock.adobe.com
March 21st 2025

CDC Launches Study on Vaccine-Autism Link Amid Ongoing Measles Outbreak

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Blood test for C3, C4 protein detection | Image Credit: © MdBabul - stock.adobe.com
March 21st 2025

Iptacopan Receives Third FDA Approval for Adult Patients With C3 Glomerulopathy

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

HIV virus cells. Scientifically accurate human immunodeficiency virus (HIV) close-up view. Acquired immunodeficiency syndrome AIDS 3D medical illustration.
March 19th 2025

New Data on HIV-1 Treatments, Including Biktarvy and Novel Lenacapavir Combination Regimen, Presented at CROI 2025

Luke Halpern, Assistant Editor
Vibrant Neural Connections and Brain Activity
March 19th 2025

FDA Grants Orphan Drug Designation to Radiprodil for GRIN-Related Neurodevelopmental Disorder

Luke Halpern, Assistant Editor